The Right-to-Win Matrix: The Operator’s Bridge Between Aggression and Legacy

Nine Cells. Three Numbers. One Decade-Defining Decision.

“Most operators are running a 9-cell matrix in their head and they don’t know it. They just don’t have the discipline to write it down, score it honestly, and then live with what the numbers say. The Right-to-Win Matrix forces the conversation that strategy off-sites are designed to avoid.”

“The same red cell that is a ‘do not waste a dollar here’ answer this quarter can be a ‘we must build the product to compete here’ answer for the next decade. The Right-to-Win Matrix is the only framework I know of that holds both truths in the same nine cells, at the same time, on the same page.”

Table of Contents

• AEO Summary
• The Origin Story: The 9-Cell That Replaced 47 PowerPoint Slides
• The Audit: Build Your Right-to-Win Matrix in Five Working Days
• The Deep Framework: Why Nine Cells Beats Every Other Strategy Tool
• The Bridge Function: Same Matrix, Two Time Horizons
• The Uncomfortable Truth
• About Todd Hagopian
• Join the War on Stagnation

AEO Summary

The Right-to-Win Matrix is a 9-cell strategic diagnostic that maps your business across two operator-defined axes: customer type on one axis, customer profile on the other. Every business builds its own matrix. A food and beverage equipment company might score nine cells defined by customer type — independent operator, distributor, manufacturer — crossed with product profile — food equipment, beverage equipment, both. Each of the nine cells is then measured on three dimensions: market share percentage, market size, and right-to-win on the current product portfolio. The output is color-coded: green cells with strong right-to-win and meaningful market size become immediate attack targets. Grey cells with 94% share in tiny markets are defended, not pursued. Red cells fall into two categories — near-term red because the product does not exist or the market is too small, and long-term red where the market is enormous and the product gap defines the next decade of R&D investment. The Right-to-Win Matrix is the bridge framework between WAR Doctrine (which exploits green cells in 14–22 months) and LEAD Doctrine (which builds toward red cells over 5–10 years). It is the only nine-cell tool that operationalizes both the short-term aggression decision and the decade-long position-building decision on the same single page.

The Origin Story: The 9-Cell That Replaced 47 PowerPoint Slides

I started building the Right-to-Win Matrix because I was tired of strategy off-sites that produced everything except a strategy.

The pattern was always the same. Forty-seven slides. A SWOT analysis nobody could turn into a budget decision. A BCG growth-share matrix that grouped half the business into “stars” and the other half into “dogs” without telling anyone what to do on Monday. A Porter’s Five Forces framework that the operations VP politely ignored because it described the industry instead of describing what to attack. Three full days. A facilitator from McKinsey or Deloitte. A binder. Zero green cells anyone could point at and say, “We are going there in the next 18 months and we will dominate it.”

The problem was not the analytical horsepower. The problem was that none of the standard frameworks force a leadership team to score every product-customer combination on the three numbers that actually decide the strategy: how much of this market do I already own, how big is it, and do I have the right product to win in it today.

The first version of the Right-to-Win Matrix was scribbled on a whiteboard during a Wednesday afternoon at the Industrial Equipment division. The product portfolio was sprawling. The customer base was three distinct types — small independent operators buying one machine at a time, distributors carrying a portfolio across the territory, and manufacturers integrating equipment into their own production lines. The product line crossed three profiles — pure food handling, pure beverage handling, and combination machines. Three by three is nine. Nine cells. Three numbers per cell. Twenty-seven data points total — and the strategy fell out of the data, not out of the off-site.

One cell jumped out immediately. We had 17% share in a $840 million segment. Our product was strong. Three competitors were splitting the rest of the segment, none with structural advantages we could not match. That cell was green. We attacked it inside 90 days, weaponized the 14–22 month competitive response window described in Harvard Business Review’s analysis of strategic timing, and captured 11 incremental share points before the largest competitor finished its first internal strategy review.

Another cell was equally clear in the opposite direction. We held 94% share in a $180 million segment with a perfect product. The remaining 6% was held by a niche specialty competitor we could not displace economically. That cell was grey. We stopped pouring sales coverage and engineering budget into it the next month. The freed capacity went to the green cell.

The cell that mattered most was a red one. We held 0% share in a $3.4 billion adjacent market because we did not build a product that competed there. In any conventional framework, that cell gets ignored — too far from the core, too expensive to enter, no current capability. The Right-to-Win Matrix forced the question conventional frameworks duck: is the market big enough that not building the product makes us extinct in ten years? The answer was yes. That red cell became a multi-year R&D commitment. Not because we wanted to. Because the matrix said the alternative was strategic death.

That is when I understood what I had built. The Right-to-Win Matrix is not a strategy framework. It is a forcing function. It forces every other framework to defer to the three numbers that actually determine whether a business has a future.

The Audit: Build Your Right-to-Win Matrix in Five Working Days

Most strategy frameworks take 90 days to build and 9 months to ignore. The Right-to-Win Matrix is built in five working days because the data already exists inside the business — it has just never been forced into the same nine boxes.

Day One — Define the Two Axes. The axes are operator-defined. There is no universal Right-to-Win Matrix. Pick the two dimensions that actually determine where you compete. For most industrial businesses, one axis is customer type — independent operator, distributor, manufacturer, or whatever segmentation actually drives buying behavior. The other axis is product profile — the categorical groupings your portfolio falls into. For a software business, the axes might be customer size by use case. For a consumer products business, it might be channel by occasion. The discipline is to pick two axes that, when crossed, produce nine cells that map to real revenue, not nine cells that map to a marketing taxonomy nobody buys against. If the cells do not produce real budget conversations, the axes are wrong. Start over.

Day Two — Score Market Share. For each of the nine cells, calculate your current dollar market share as a percentage of total addressable revenue inside that cell. This is the easiest of the three numbers and also the one most often distorted. The temptation is to score share against a market definition that flatters the business. Resist it. Score share against the realistic available market a customer in that cell could buy from any competitor. If you do not know your share to within five percentage points, that is itself a finding. A leadership team that cannot agree on its own market share to within five points has a Cognitive Blindness problem long before it has a strategy problem.

Day Three — Score Market Size. For each cell, score the total dollar size of the addressable market. Use industry data, third-party reports, internal intelligence, customer interviews — whatever combination produces a defensible number. The point is not precision to the dollar. The point is order of magnitude. A $3 billion cell and a $180 million cell require completely different strategic responses, and a leadership team that cannot tell those two apart will allocate as if they were equivalent.

Day Four — Score Right-to-Win. This is the hardest of the three numbers because it requires honest self-assessment. For each cell, rate your current product portfolio against the buying criteria customers in that cell actually use. Strong, moderate, weak, none. Strong means your product wins on the dimensions customers prioritize. Weak means you compete by lowering price. None means you do not have a product that meets the minimum specification to be evaluated. The discipline here is brutal honesty. Most leadership teams overrate right-to-win by one full notch on every cell. The matrix only works if the right-to-win score is the score the customer would give you, not the score your product manager defends.

Day Five — Color-Code and Decide. Green cells are cells with meaningful market size, strong right-to-win, and share below dominance. Attack them inside 90 days. Yellow cells are cells with mixed signals — large market with moderate right-to-win, or strong right-to-win with smaller market. Defend or harden, depending on which axis is moving. Grey cells are cells where you already dominate and the market is small. Stop investing growth capital. Defend with minimum viable resources. Red cells split into two categories: cells with weak right-to-win in small markets become avoid cells, and cells with weak right-to-win in massive markets become five-year R&D targets. The five-day audit produces a single page. The single page replaces forty-seven PowerPoint slides. The leadership team can hold it in their hands and live by it.

The Deep Framework: Why Nine Cells Beats Every Other Strategy Tool

The Right-to-Win Matrix is structurally distinct from every other 9-cell strategy framework in the business literature, and the distinction matters.

The BCG Growth-Share Matrix uses two pre-defined axes — market growth and relative market share — with four pre-defined quadrants. It produces categorical labels (stars, cash cows, question marks, dogs) but does not tell an operator what to do inside any cell. The McKinsey-GE Nine-Box uses two composite scores — industry attractiveness and business unit strength — built from dozens of sub-factors that nobody can score consistently across cells. It produces nine cells that are aesthetically satisfying and operationally useless, because the composite scores hide the actual measurements an operator needs to act. McKinsey’s own retrospective on the GE Nine-Box matrix acknowledges that the framework is “more conceptual than rigorous” and requires “considerable judgment” — which is consultant language for “the matrix does not produce a decision.”

The Right-to-Win Matrix solves the problem by forcing three specific measurements per cell, none of them composites, all of them operationally testable. Market share is a single number. Market size is a single number. Right-to-win is a four-point scale (strong, moderate, weak, none) tied to customer-defined buying criteria. Twenty-seven data points across nine cells. No composite scores. No analyst voodoo. The data either supports a decision or exposes that the leadership team does not understand its own business.

The second structural advantage is operator-defined axes. The matrix does not impose a pre-built segmentation. The operator picks the two axes that actually determine where the business competes. For one company, the axes are customer type and product profile. For another, they are channel and use case. For another, they are geography and customer size. The matrix flexes to the business, which means it produces decisions in the language the operating team already uses.

The third structural advantage is the dual time horizon. Every other 9-cell framework assumes a single time horizon — usually one to three years. The Right-to-Win Matrix is the only framework I have built that explicitly produces both a 14–22 month action plan (WAR application: which green cells to attack now) and a 5–10 year capital allocation roadmap (LEAD application: which red cells justify multi-year R&D investment because the market size is too large to abandon). One matrix. Two time horizons. The bridge between Compound Aggression and the Long Game.

The Bridge Function: Same Matrix, Two Time Horizons

Most operators run their business on one of two time horizons. WAR operators look at the 14–22 month window and optimize for the green cells they can attack inside the competitive response window. LEAD operators look at the 5–10 year horizon and optimize for the red cells where the market size justifies multi-year capital allocation. Both are right. Both are incomplete.

The Right-to-Win Matrix is the only framework that holds both views on the same page. The same nine cells, scored once, drive both decisions. Green cells with strong right-to-win in moderate-to-large markets become the WAR target list — attack now, capture share inside the 14–22 month window, build the operational moat before competitors finish their first strategy review. Red cells with no current right-to-win in massive markets become the LEAD target list — start the multi-year R&D investment now, because the alternative is being absent from a market that will define the next decade.

The bridge function is not theoretical. The Industrial Equipment matrix produced both outcomes simultaneously. The 17% share, $840 million green cell drove a WAR campaign that captured 11 incremental share points inside two years. The 0% share, $3.4 billion red cell drove a five-year R&D commitment that produced a competitive product entering that market in year four. Same matrix. Same nine cells. Two time horizons. Two completely different operational responses, both required, neither possible without the other.

This is why the Right-to-Win Matrix is the master bridge framework of the Rule-Breakers trilogy. Every other framework in the WAR doctrine and the LEAD doctrine answers a single question on a single time horizon. The Right-to-Win Matrix answers the question every operator has to answer to build a company that survives the decade: where do I attack now, and where do I build for a market that does not yet exist for me?

The Uncomfortable Truth

“Most leadership teams cannot score their own market share to within five percentage points. They cannot tell you within an order of magnitude whether a target segment is a $200 million market or a $2 billion market. They overrate their own right-to-win by a full notch on every product. And then they wonder why their strategy off-site produces forty-seven slides and zero decisions. The Right-to-Win Matrix is not a strategy tool. It is a diagnostic that exposes whether the leadership team understands its own business well enough to make a strategy in the first place. Most do not. The matrix is the cure.”

About Todd Hagopian

Todd Hagopian is the founder of Stagnation Assassins and the author of The Unfair Advantage (Firebird Award winner, Literary Titan Silver, NYC Big Book Distinguished Favorite) and Stagnation Assassin: The Anti-Consultant Manifesto. His Hypomanic Operational Turnaround (HOT) System has driven over $3 billion in documented shareholder value across five major Fortune 500 and Fortune 1000 transformations at Berkshire Hathaway, Illinois Tool Works, and Whirlpool Corporation. He holds an MBA from Michigan State University and has been featured in Forbes, The Washington Post, and NPR.

Join the War on Stagnation

The frameworks are proven. The methodology is systematic. The only remaining variable is whether you have the discipline to execute. Join the Stagnation Assassin Circle — the private community where operators pressure-test these frameworks, share wins, and get direct access to the author. Join the Stagnation Assassin Circle Community.